Connect
MJA
MJA

Ethics and law

Letters

Comment: Privacy legislation and research

Kerry J Breen and Sandra M Hacker

Med J Aust 2002; 177 (9): 523-524

Letters

Comment: Privacy legislation and research

Loane LC Skene

Med J Aust 2002; 177 (9): 524

Editorials

The ethics of participating in research

Annette J Braunack-Mayer

Med J Aust 2002; 177 (9): 471-472

The Research Enterprise

Does research into sensitive areas do harm? Experiences of research participation after a child's diagnosis with Ewing's sarcoma

Debbie A Scott, Frances M Boyle, Christopher J Bain and Patricia C Valery

Med J Aust 2002; 177 (9): 507-510 Free

Letters

RARE SALAMI trial revisited

Helge H Rasmussen, Peter S Hansen and Gregory I C Nelson

Med J Aust 2002; 177 (8): 462

Letters

In reply: RARE SALAMI trial revisited

Michael C Kennedy

Med J Aust 2002; 177 (8): 462-463

Medicine and the media

Media coverage of scientific presentations

Julie Robotham and Robert Whitehead

Med J Aust 2002; 177 (7): 375-375

Medicine and the media

Media coverage of scientific presentations

Terry D Bolin and James V Bertouch

Med J Aust 2002; 177 (7): 374-374

Editorials

Drug advertising: truths, half-truths and few statistics

David A Newby and David A Henry

Med J Aust 2002; 177 (6): 285-286

Research

Pharmaceutical advertisement claims in Australian medical publications

Tim W Loke, Fong Chee Koh and Jeanette E Ward

Med J Aust 2002; 177 (6): 291-293 Free

The profession

Humanistic medicine or values-based medicine . . . what's in a name?

J Miles Little

Med J Aust 2002; 177 (6): 319-321 Free

Editorials

The xenotransplantation research debate: time to involve the community

Kerry J Breen, on behalf of the NHMRC Working Party on Xenotransplantation

Med J Aust 2002; 177 (4): 175

Letters

The intention to hasten death of terminally ill patients

Mathew Piercy, Gerald B Fogarty, Aubrey W Jansz, David M Gawler, Luis Vitetta, David Kenner and Avni Sali

Med J Aust 2002; 177 (3): 165-167

Letters

The intention to hasten death of terminally ill patients

Mathew Piercy, Gerald B Fogarty, Aubrey W Jansz, David M Gawler, Luis Vitetta, Avni Sali Professor and and David Kenner

Med J Aust 2002; 177 (3): 165-167

Letters

Confidentiality

Peter C Arnold, Bernadette M Tobin, Steven R Leeder and Ernest R Somerville

Med J Aust 2002; 177 (1): 165

Letters

Confidentiality

Peter C Arnold, Bernadette M Tobin, Steven R Leeder and Ernest R Somerville

Med J Aust 2002; 177 (1): 165

Letters

End-of-life issues

Susan E Kurrle

Med J Aust 2002; 177 (1): 54-55

Letters

End-of-life issues

Susan E Kurrle, Bernadette M Tobin and Ian D Cameron

Med J Aust 2002; 177 (1): 54-55

For debate

Clinical trials without consent: some experiments simply cannot be done

Michael C Kennedy

Med J Aust 2002; 177 (1): 40-42

Letters

Medical indemnity

Paul Gerber

Med J Aust 2002; 177 (1): 51

Editorials

A change in the make-up of medicine

Trevor J Mudge and Dorothy A Dashwood

Med J Aust 2002; 176 (12): 569-570

Viewpoint

Using "anti-ageing" to market cosmetic surgery: just good business, or another wrinkle on the face of medical practice?

Anne L Ring

Med J Aust 2002; 176 (12): 597-599

Letters

In reply: Hindsight bias in medicolegal expert reports

Thomas B Hugh and G Douglas Tracy

Med J Aust 2002; 176 (10): 505-506

Clinical ethics

Development of guidelines for non-Indigenous people undertaking research among the Indigenous population of north-east Victoria

Rick Henderson, David S Simmons, Lisa Bourke and Janice Muir

Med J Aust 2002; 176 (10): 482-485 Free

Letters

Hindsight bias in medicolegal expert reports

Peter C Arnold

Med J Aust 2002; 176 (10): 504-505